Get Our Free Research Email
Conference Calendar 
May 20-23 - Current Concepts in Joint Replacement Spring 2012
May 23-25 - 13th EFORT Congress 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
September 2007
Legal Federal prosecutors announced on Thursday the terms of a settlement with Zimmer, Depuy, Biomet, Smith & Nephew and Stryker following an investigation into physician compensation practices. Zimmer, Depuy, Biomet and Smith & Nephew entered into deferred prosecution agreements and... more
Federal prosecutors announced today the terms of a settlement with Zimmer, Depuy, Biomet, Smith & Nephew and Stryker following an investigation into physician kickbacks. Zimmer, Depuy, Biomet and Smith & Nephew entered into deferred prosecution agreements (where a company can... more
CARLSBAD, Calif., Sep 25, 2007 -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced that Canaccord Adams Inc., the sole underwriter of... more
ReGen Biologics today announced it received a "Not Substantially Equivalent" (NSE) letter from the FDA in response to the 510(k) premarket notification the company submitted for its meniscal repair implant. In a press release and conference call, a clearly frustrated... more
CARLSBAD, Calif., Sep 21, 2007 -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced the pricing of its public offering of 8,800,000... more
Earnings AOI Medical reported a 1H:07 loss of $1.8 million, increasing from a loss of $0.97 million in the comparable half. The company attributed the loss to increased expenses. They expect their product, the Balloon Assisted Management of Spine Fractures,... more
As published in the Lancet this week, results of a new trial showed that a pill called dabigatran etexilate (DE) was as effective as the injected drug enoxaparin in reducing the risk of blood clots following total hip replacement. DE... more
J. Kevin McGraw, MD, FSIR is the Co-Director of Vascular and Interventional Radiology Riverside Methodist Hospital in Columbus, Ohio and a Clinical Assistant Professor of Radiology at the Medical College of Ohio in Toledo, Ohio. He currently serves on... more
Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced the entry into an exclusive worldwide license for a unique minimally invasive guided lumbar... more
Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran marketing executive, Kathryn Liljestrand, has joined the company as Vice President... more
M&A Medtronic and Kyphon announced that the FTC and the U.S. Department of Justice antitrust division granted early termination of the waiting period for the companies' merger. Additional antitrust authorities must still approve the transaction, which is expected to close... more
Alphatec Holdings, Inc. (NASDAQ: ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced the entry into an exclusive worldwide license for a unique vertebroplasty technology system... more
Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced plans to offer 8,000,000 shares of common stock pursuant to an effective registration statement... more
Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran operations executive, Kermit Stott, has joined the company as Vice... more
The July U.K. edition of JBJS reported results of a study evaluating the impact of the U.K.'s National Institute for Health and Clinical Excellence (NICE) guidelines for hip replacements. NICE publishes guidelines to promote "good health and the prevention and... more
At the confluence of war and improved medical care sit the 130 U.S. veterans of the current war in Iraq who have had an arm amputated. Advances in battlefield medical care have allowed soldiers who would have died in combat... more
Regulatory Inion Oy received FDA approval for its implant material BioRestore in dental and cranio-maxillofacial applications. The product is designed to fill bony voids or gaps in the skeleton. BioRestore is currently being reviewed by the FDA for use in... more
Yesterday afternoon Biomet announced that its acquisition by a private equity consortium was approved by the Company's shareholders at the increased price of $46.00 per share. According to a preliminary tally, 91.56% of the total shares outstanding voted in favor... more
Following recent FDA approval of its Prestige artificial cervical disc, Medtronic announced the launch of a new advertising campaign aimed at Hispanics. The campaign, which was announced in a press release, features a Spanish-language website. In the press release, Dr.... more
Complete Archive
|
